Epigenetic aberrations play important roles in cancer development and progression. To understand how epigenetic processes contribute to cancer, we have established the Epigenetics Innovation Lab, which provides MSK researchers with state-of-the-art epigenomic profiling assays to study cancer-associated changes in chromatin accessibility, DNA methylation, and histone modifications. The Epigenetics Innovation Lab offer consultation on an array of epigenetics techniques to fit a large variety of research needs. We also welcome the opportunity to collaborate with the teams/researchers interested in developing new techniques to support projects related to epigenomics.
For more information about the Epigenetics Innovation Lab, including lists of established available assays and new assays in development, please click here.